Fig. 2.

Design, processing, and animals experiments of hMN enhanced CAP mediated therapy: (A) Illustration of the transdermal CAP mediated immune checkpoint blockade therapy; (B) Penetration test of the CAP through hMN patch (Scale bar, 1 cm); (C) Schematic of B16F10 melanoma-bearing mice with different treatments. Reprinted with permission from Ref. [72].